6 research outputs found
Lattice Boltzmann Simulations of Supercritical CO<sub>2</sub>–Water Drainage Displacement in Porous Media: CO<sub>2</sub> Saturation and Displacement Mechanism
CO<sub>2</sub> geosequestration in deep aquifers requires the displacement
of water (wetting phase) from the porous media by supercritical CO<sub>2</sub> (nonwetting phase). However, the interfacial instabilities,
such as viscous and capillary fingerings, develop during the drainage
displacement. Moreover, the burstlike Haines jump often occurs under
conditions of low capillary number. To study these interfacial instabilities,
we performed lattice Boltzmann simulations of CO<sub>2</sub>–water
drainage displacement in a 3D synthetic granular rock model at a fixed
viscosity ratio and at various capillary numbers. The capillary numbers
are varied by changing injection pressure, which induces changes in
flow velocity. It was observed that the viscous fingering was dominant
at high injection pressures, whereas the crossover of viscous and
capillary fingerings was observed, accompanied by Haines jumps, at
low injection pressures. The Haines jumps flowing forward caused a
significant drop of CO<sub>2</sub> saturation, whereas Haines jumps
flowing backward caused an increase of CO<sub>2</sub> saturation (per
injection depth). We demonstrated that the pore-scale Haines jumps
remarkably influenced the flow path and therefore equilibrium CO<sub>2</sub> saturation in crossover domain, which is in turn related
to the storage efficiency in the field-scale geosequestration. The
results can improve our understandings of the storage efficiency by
the effects of pore-scale displacement phenomena
MOESM1 of Ground uplift related to permeability enhancement following the 2011 Tohoku earthquake in the Kanto Plain, Japan
Additional file 1. Table S1. SAR acquisition dates and perpendicular baselines. Bperp indicates perpendicular component of baseline
Treatment with silver nitrate versus topical steroid treatment for umbilical granuloma: A non-inferiority randomized control trial
<div><p>Objective</p><p>The aim of this prospective multicenter randomized controlled trial was to compare the efficacy of silver nitrate cauterization against that of topical steroid ointment in the treatment of neonatal umbilical granuloma.</p><p>Methods</p><p>An open-label, non-inferiority randomized controlled trial was conducted from January 2013 to January 2016. The primary endpoint for the silver nitrate cauterization and topical steroid ointment groups was the healing rate after 2 weeks of treatment, applying a non-inferiority margin of 10%. The healing rate was evaluated until completion of 3 weeks of treatment.</p><p>Results</p><p>Participants comprised 207 neonates with newly diagnosed umbilical granuloma, randomized to receive silver nitrate cauterization (n = 104) or topical steroid ointment (n = 103). Healing rates after 2 weeks of treatment were 87.5% (91/104) in the silver nitrate cauterization and 82% (82/100) in the topical steroid ointment group group. The difference between groups was -5.5% (95% confidence interval, -19.1%, 8.4%), indicating that the non-inferiority criterion was not met. After 3 weeks of treatment, the healing rate with topical steroid ointment treatment was almost identical to that of silver nitrate cauterization (94/104 [90.4%] vs. 91/100 [91.0%]; 0.6% [-13.2 to 14.3]). No major complications occurred in either group.</p><p>Conclusions</p><p>This study did not establish non-inferiority of topical steroid ointment treatment relative to silver nitrate cauterization, presumably due to lower healing rates than expected leading to an underpowered trial. However, considering that silver nitrate cauterization carries a distinct risk of chemical burns and that the overall efficacy of topical steroid ointment treatment is similar to that of silver nitrate cauterization, topical steroid ointment might be considered as a good alternative in the treatment of neonatal umbilical granuloma due to its safety and simplicity. To clarify non-inferiority, a larger study is needed.</p></div
CONSORT flow diagram.
<p>Progression of patients through the trial up to 3 weeks of treatment in all participating centers. No patients dropped out due to adverse events in either group.</p
Umbilical granuloma healing rate after 1, 2 and 3 weeks of treatment.
<p>Umbilical granuloma healing rate after 1, 2 and 3 weeks of treatment.</p